Maxwell Sherman

Co-Founder & CTO @ Serinus Biosciences (YC S22)

Co-founder

Serinus Biosciences· Summer 2022 Greater Boston

in LinkedIn 𝕏 @m_a_sherman

2022Co-founder· Serinus Biosciences

Founder · since 2022

Company

Serinus Biosciences

Role

Co-founder & CTO

current

Stage

—

no public source

Raised

—

no public source

Based

—

Founder / co-founder — the company's markEmployee / research role

Source: LinkedIn work history

Profile coverage5 of 7 · missing posts, contact

Serinus Biosciences

Combinations therapy by rational design

Summer 2022

Experience

Career

Serinus Biosciences
Co-founder
Co-founder & CTO · 2022 – Present
2022
Massachusetts Institute of Technology
Doctoral Researcher · 2018 – 2022
2018
Brigham and Women's Hospital
Graduate Research Fellow · 2018 – 2022
2018
Harvard Medical School
Graduate Research Fellow · 2018 – 2022
2018
Harvard Medical School
Scientific Programmer · 2016 – 2018
2016
Broad Institute of MIT and Harvard
Research Associate · 2018 – 2022
2018
Brown University
Research Assistant · 2012 – 2014
2012
Brown University
Emergency Medical Technician · 2010 – 2014
2010

Bio

After five years as a paramedic, Max left clinical medicine to develop new treatments for the millions of patients without access to effective medications. He studied applied math and biology at Brown University, statistics at Cambridge University, and is completing his PhD in computational biology at MIT. His research has appeared in prestigious journals including Science, Nature Biotechnology, and Nature Neuroscience and has been recognized with national and international awards.